|Articles|August 9, 2016
Evidera to Join PPD
PPD announces the acquisition of Evidera, an evidence-based solutions provider.
Advertisement
PPD announces the acquisition of Evidera, an evidence-based solutions provider. As a subsidiary of PPD, Evidera will be deliver peri- and post-approval studies, health economics, outcomes research, epidemiology and market access consulting.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5